Dianthus Therapeutics, Inc. /DE/ - Common Stock, $0.001 par value per share (DNTH)

CUSIP: 252828108

Q1 2026 13F Holders as of 31 Mar 2026

Security identity
Security type / class
Equity / Common Stock, $0.001 par value per share
Shares outstanding
54,411,104
Holder snapshot
Total 13F shares
61,200,715
Share change
+12,750,077
Total reported value
$5,135,825,058
Put/Call ratio
110%
Reported price per share
$83.92
Number of holders
239
Value change
+$1,101,913,534
Number of buys
171
Number of sells
72

Security key

252828108

Report period

Q1 2026

Institutions

239

Top holders

10

DNTH full security history Ownership snapshot Full 13F holder table Previous quarter: Q4 2025 Dianthus Therapeutics, Inc. /DE/ SEC filings Dianthus Therapeutics, Inc. /DE/ company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of DNTH - Dianthus Therapeutics, Inc. /DE/ - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
FMR LLC
13D/G signal
FMR LLC
Evidence rows
15
Latest as of
31 Mar 2026
13F 13D/G 3/4/5 Lead comparable stake: 15% 13D/G row: FMR LLC Showing 1-6 of 15 holder rows.

Rank 1 holder

FMR LLC

13F 13D/G
Ownership
15%
Position
$265.04M
13F 13D/G
Holder Evidence Ownership % Position 12M Net Δ As of
FMR LLC
13F 13D/G
Company
13F 13D/G
15%
from 13D/G
$265,035,068
6,431,329 shares
 — 31 Dec 2025
Sirenia Capital Management LP
13D/G
13D/G
5.3%
$256,475,863
2,798,122 shares
 $0 31 Mar 2026
BlackRock, Inc.
13D/G 13F
Company
13D/G 13F
5.1%
$221,045,616
2,634,004 shares
 +$86,760,776 31 Mar 2026
Fairmount Funds Management LLC
13F 13D/G 3/4/5
Company · Director
13F 13D/G 3/4/5
4.9%
from 13D/G
$88,073,641
2,137,191 shares
 — 31 Dec 2025
Avidity Partners Management LP
13F 13D/G
Company
13F 13D/G
4.9%
from 13D/G
$86,713,423
2,104,184 shares
 — 31 Dec 2025
RA CAPITAL MANAGEMENT, L.P.
13D/G 13F
Company
13D/G 13F
4.8%
$239,391,447
2,611,733 shares
 $0 31 Mar 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
239
Shares
61,200,715
Rows available
239
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 holders
167
Q1 2026 holders
239
Holder diff
72
Investor Q4 2025 Shares Q1 2026 Shares Share Diff Share Chg % Q4 2025 value Q1 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .